Home Diagnostics has signed a deal that will allow it to integrate its TRUE blood glucose testing device with Cellnovo's wireless mobile handset technology to enable patients to track their blood sugar using touch-screen computers. Cellnovo CEO Bill McKeon said the agreement allows his company to benefit from Home Diagnostics' distribution network, insurance firms and product suppliers.

Related Summaries